Indaptus Therapeutics Stock Market Value
| INDP Stock | USD 1.80 0.25 16.13% |
| Symbol | Indaptus |
Can Biotechnology industry sustain growth momentum? Does Indaptus have expansion opportunities? Factors like these will boost the valuation of Indaptus Therapeutics. Market participants price Indaptus higher when confident in its future expansion prospects. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Indaptus Therapeutics demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Understanding Indaptus Therapeutics requires distinguishing between market price and book value, where the latter reflects Indaptus's accounting equity. The concept of intrinsic value - what Indaptus Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Indaptus Therapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Indaptus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Indaptus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Indaptus Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Indaptus Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Indaptus Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Indaptus Therapeutics.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Indaptus Therapeutics on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Indaptus Therapeutics or generate 0.0% return on investment in Indaptus Therapeutics over 90 days. Indaptus Therapeutics is related to or competes with Biomotion Sciences, Revelation Biosciences, Psyence Biomedical, GT Biopharma, Avenue Therapeutics, Protagenic Therapeutics, and Lipella Pharmaceuticals. Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunothe... More
Indaptus Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Indaptus Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Indaptus Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 51.64 | |||
| Value At Risk | (13.41) | |||
| Potential Upside | 16.13 |
Indaptus Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Indaptus Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Indaptus Therapeutics' standard deviation. In reality, there are many statistical measures that can use Indaptus Therapeutics historical prices to predict the future Indaptus Therapeutics' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.66) | |||
| Total Risk Alpha | (1.30) | |||
| Treynor Ratio | (0.1) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Indaptus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Indaptus Therapeutics February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.09) | |||
| Mean Deviation | 6.23 | |||
| Coefficient Of Variation | (2,626) | |||
| Standard Deviation | 8.72 | |||
| Variance | 76.08 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.66) | |||
| Total Risk Alpha | (1.30) | |||
| Treynor Ratio | (0.1) | |||
| Maximum Drawdown | 51.64 | |||
| Value At Risk | (13.41) | |||
| Potential Upside | 16.13 | |||
| Skewness | 1.24 | |||
| Kurtosis | 3.76 |
Indaptus Therapeutics Backtested Returns
Indaptus Therapeutics holds Efficiency (Sharpe) Ratio of -0.0462, which attests that the entity had a -0.0462 % return per unit of risk over the last 3 months. Indaptus Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Indaptus Therapeutics' Market Risk Adjusted Performance of (0.09), risk adjusted performance of (0.02), and Standard Deviation of 8.72 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 3.6, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Indaptus Therapeutics will likely underperform. At this point, Indaptus Therapeutics has a negative expected return of -0.41%. Please make sure to check out Indaptus Therapeutics' total risk alpha, as well as the relationship between the kurtosis and day typical price , to decide if Indaptus Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.01 |
Very weak reverse predictability
Indaptus Therapeutics has very weak reverse predictability. Overlapping area represents the amount of predictability between Indaptus Therapeutics time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Indaptus Therapeutics price movement. The serial correlation of -0.01 indicates that just 1.0% of current Indaptus Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.01 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.23 |
Pair Trading with Indaptus Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Indaptus Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Indaptus Stock
The ability to find closely correlated positions to Indaptus Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Indaptus Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Indaptus Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Indaptus Therapeutics to buy it.
The correlation of Indaptus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Indaptus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Indaptus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Indaptus Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Indaptus Stock Analysis
When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.